Drug data last refreshed 12h ago · AI intelligence enriched 5d ago
Nitrogen, NF is an inhalation gas product approved by the FDA in 2018 under NDA classification by Universal Cells. It is a non-pharmacologic medical gas with no traditional mechanism of action or pharmacologic class, used as an inhalation therapy. The product's clinical indications and therapeutic applications are not publicly detailed in available labeling data.
Product is in peak lifecycle stage with moderate competitive pressure (30%), suggesting a stable but competitive market environment requiring focused commercial execution.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts
Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts
Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care
Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness
The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients
Worked on NITROGEN, NF at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Zero linked job openings currently exist for this product, reflecting either mature team staffing or limited commercial expansion plans at Universal Cells. Career opportunities on Nitrogen, NF would center on sustaining commercial execution in a niche specialty gas market rather than growth initiatives.